News and events


Ready, set, go for crossing the barrier!

Researchers at the CRG, GRIB (UPF-IMIM) and Helmholtz Center have discovered a new mechanism controlling the expression of a set of genes important for cell proliferation and tumour progression.

A new therapy proves effective against brain metastasis

A study published in Nature Medicine by a team led by researchers at the Spanish National Cancer Research Centre (CNIO), with the participation of Mind the Byte, shows that the administration of silibinin in patients with brain metastasis reduces lesions without causing any adverse effects.

Minimalist Biostructures Designed to Create Nanomaterials

Researchers of the Institute of Biotechnology and Biomedicine (IBB-UAB) have achieved to generate 4 peptides -molecules smaller than proteins - capable of self-assembling in a controlled manner to form nanomaterials.

Bioinformatics firm Mind the Byte acquires Intelligent Pharma

The deal enables Mind the Byte, a pioneer in developing cloud technologies for computational drug design, to secure its leadership on the Spanish market and furthers its plans to become one of the key companies in the industry in Europe

Mind the Byte and Prosilico sign a strategic partnership agreement

Together, the two companies will provide a broad portfolio of in silico models covering most aspects of virtual drug discovery and development. Prosilico software will now be included in Mind the Byte's SaaS platform and both firms will promote each other's technologies.

Genomics prepares to jump to three dimensions

20 world leaders in 3D genomics will meet today until Wednesday in Barcelona at the Barcelona BioMed Conference organized by IRB Barcelona and the BBVA Foundation.

Open innovation improving drug safety evaluation

The Hospital del Mar Medical Research Institute (IMIM) and the Pompeu Fabra University (UPF) have just published a comment in the prestigious journal Nature Reviews Drug Discovery where they explain the excellent results from eTOX, a project that has facilitated a new model for collaboration among pharmaceutical companies, as well as between these and academia, where data and knowledge are shared for the purposes of improving the toxicological evaluation of drugs.

Graduació de la primera promoció de titulats en el cicle de Desenvolupament d'Aplicacions Web, adaptat al perfil de Bioinformàtica

S'han graduat nou alumnes de l'Institut Provençana de l'Hospitalet de Llobregat i dos del centre Gimbernat Formació de Sant Cugat del Vallès L'objectiu del cicle és formar tècnics informàtics amb coneixements en ciències de la vida que els capaciti per entendre els conceptes bàsics i les eines bioinformàtiques més comunes utilitzades en el sector   El dijous 14 de setembre ha tingut lloc l'acte de lliurament de diplomes a la primera promoció de graduats del cicle de grau superior de Desenvolupament d'Aplicacions Web, adaptat al perfil professional de Bioinformàtica.

40 Million EUR european project for new drug safety assessment and integrative data analysis research

The five-year project eTRANSAFE: Enhancing Translational Safety Assessment through Integrative Knowledge Management, aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the security in drug development process and is funded by the Innovative Medicines Initiative (IMI 2) together with the pharmaceutical industry.

Èxit del Workshop sobre Bioinformàtica per a enginyers

L'Auditori Pompeu Fabra de la seu dels Enginyers Industrials Catalunya ha acollit el dimarts 11 de juliol un workshop gratuït organitzat per l'Associació Bioinformatics Barcelona (BIB) i el Col·legi Oficial d'Enginyeria en Informàtica de Catalunya (COEINF).

Researchers describe the complete epigenomes of the most frequent tumours

A team of researchers led by the lecturer Manel Esteller, ICREA researcher in the Bellvitge Biomedical Research Institute (IDIBELL) and the Faculty of Medicine and Health Sciences of the University of Barcelona, have characterized the complete epigenomes of the most common tumours, among which are the ones from colon cancer, lung cancer and breast cancer.

VET in bioinformatics, a good way to attract young talent

Vocational Education and Training (commonly known as VET) in bioinformatics is sure to be a way for many young people to enter the job market and a good gateway to companies in the healthcare and life sciences sector looking to add junior technicians to their teams, not just PhDs.

Genetic signature of natural selection in first Americans

When 18,000 years ago humans entered America through the Bering Strait they found a totally different climate and food. A recent study published in the journal Proceedings of the National Academy of Sciences USA (PNAS) shows that this migration left traces in the genome of Native Americans, descendants of those early settlers.

The fundamental causes of human ageing explained

Natural selection favours fragile and unhealthy old age if it is due to mutations that are beneficial during childhood. As of 40-50 years of age, natural selection is blind because we have already passed on our genes, whether beneficial or not, to our descendants.

Key genes for disease

Scientists at the IBE find common features in genes associated with diseases. The study, published in the journal Human Molecular Genetics, suggests a degree of biological importance in the genome depending on the linkage of genes to disease

Enrolment opened for the Graduate Diploma in Big Data Processing for Life Sciences

Enrolment is open for the Graduate Diploma in Big Data Processing for Life Sciences offered by the Universitat Autònoma de Barcelona. This new programme will begin on 17 February and is offered in collaboration with several institutions, such as Fundació i2cat, Hospital Sant Joan de Déu, IDIAP Jordi Gol, Consorci Hospitalari Parc Taulí and the Centre for Genomic Regulation (CRG).

Sequentia Biotech launches Gaia, the first intuitive metagenomics SAAS tool

Sequentia Biotech, based at the Barcelona Science Park, recently developed Gaia, an online bioinformatics tool able to manage and analyze metagenomic data from any microbial community (bacteria, viruses and eukaryotes) generated by Next Generation Sequencing technologies (NGS) applied to human, animal and plant genetics.

Es constitueix l’Associació Bioinformatics Barcelona - BIB

L'associació BIB compta amb 25 entitats membres entre universitats, centres de recerca, instituts de recerca hospitalària, grans infraestructures científiques, empreses i altres institucions, a més de 23 entitats en procés d'incorporació.